How microbes make drug-like chemicals without damaging themselves
University of Michigan researchers have discovered a mechanism that enables microscopic organisms like bacteria and fungi to produce drug-like molecules—compounds that can fight infections or kill cancer cells—without damaging themselves.
Researchers at the University of Michigan have uncovered a mechanism by which microbes like bacteria and fungi can create drug-like compounds without harming themselves. This discovery, published in Science, could lead to the development of new pharmaceuticals and improve the effectiveness of existing natural product therapeutics.
The team studied Streptomyces bacteria, which produce doxorubicin, a widely used anticancer drug. The bacteria generate doxorubicin through a process involving an enzyme called CYP450, but the conditions required for efficient production also degrade the drug. The researchers discovered that a gene called DnrV, located adjacent to the CYP450 gene, is crucial for preserving the drug molecule.
The DnrV protein not only protects the bacteria from harmful byproducts of the chemical reactions but also enhances the efficiency of the CYP450 enzyme. By analyzing the genome of Streptomyces, the researchers found over 40,000 related proteins with similar protective functions across bacteria, fungi, and plants. These proteins, dubbed REACT proteins, could serve as markers to identify biologically important natural products and aid in the discovery of new drug-like compounds.
Written by urgent.news from Phys.org's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.